Prognostic impact of pretreatment serum superoxide dismutase activity in patients with locoregionally advanced nasopharyngeal carcinoma.

Wen-Ze QiuJiali JiangZejiang ZhanLaiji HuangJin DengJiacai YeGuo LiKai LiaoHuanhuan ZhangYan DingYa-Wei YuanRonghui Zheng

Published in: The International journal of biological markers (2022)

Serological SOD activity before treatment is an important prognostic indicator for patients with stage III-IV non-metastatic nasopharyngeal carcinoma undergoing chemoradiation therapy.

Keyphrases

squamous cell carcinoma
small cell lung cancer
rectal cancer
amyotrophic lateral sclerosis
mesenchymal stem cells
nitric oxide
combination therapy
bone marrow
replacement therapy